Cellectis SA (CLLS)
3.25
-0.05
(-1.52%)
USD |
NASDAQ |
Sep 02, 16:00
3.26
+0.01
(+0.31%)
After-Hours: 20:00
Cellectis Cash and Short Term Investments (Quarterly) : 166.85M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 166.85M |
| March 31, 2026 | 185.66M |
| December 31, 2025 | 208.66M |
| September 30, 2025 | 192.22M |
| June 30, 2025 | 198.15M |
| March 31, 2025 | 243.69M |
| December 31, 2024 | 260.31M |
| September 30, 2024 | 260.95M |
| June 30, 2024 | 272.81M |
| March 31, 2024 | 213.10M |
| December 31, 2023 | 203.82M |
| September 30, 2023 | 67.36M |
| June 30, 2023 | 85.51M |
| March 31, 2023 | 88.16M |
| December 31, 2022 | 97.70M |
| September 30, 2022 | 119.01M |
| June 30, 2022 | 153.63M |
| March 31, 2022 | 155.37M |
| December 31, 2021 | 186.14M |
| September 30, 2021 | 211.10M |
| June 30, 2021 | 251.62M |
| March 31, 2021 | 225.90M |
| December 31, 2020 | 268.24M |
| Date | Value |
|---|---|
| September 30, 2020 | 302.18M |
| June 30, 2020 | 311.09M |
| March 31, 2020 | 346.14M |
| December 31, 2019 | 360.91M |
| September 30, 2019 | 362.87M |
| June 30, 2019 | 397.36M |
| March 31, 2019 | 421.84M |
| December 31, 2018 | 451.89M |
| September 30, 2018 | 475.91M |
| June 30, 2018 | 491.09M |
| March 31, 2018 | 282.06M |
| December 31, 2017 | 296.98M |
| September 30, 2017 | 305.04M |
| June 30, 2017 | 271.01M |
| March 31, 2017 | 276.51M |
| December 31, 2016 | 291.34M |
| September 30, 2016 | 296.65M |
| June 30, 2016 | 299.65M |
| March 31, 2016 | 216.96M |
| December 31, 2015 | 341.36M |
| September 30, 2015 | 311.83M |
| June 30, 2015 | 316.31M |
| March 31, 2015 | 127.15M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Akari Therapeutics Plc | 7.754M |
| EDAP TMS SA | 21.54M |
| Autolus Therapeutics Plc | 203.13M |
| Evaxion AS | 14.00M |